Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.

导出 LinkOut

翻译打印收藏纠错

第一作者： M,Mokhtarani

第一单位： Horizon Pharma, Brisbane, CA, USA.

作者： M,Mokhtarani ^[1] ; G A,Diaz ^[2] ; U,Lichter-Konecki ^[3] ; S A,Berry ^[4] ; J,Bartley ^[5] ; S E,McCandless ^[6] ; W,Smith ^[7] ; C,Harding ^[8] ; C,Le Mons ^[9] ; D F,Coakley ^[1] ; B,Lee ^[10] ; B F,Scharschmidt ^[1]

作者单位： Horizon Pharma, Brisbane, CA, USA. ^[1] Mount Sinai School of Medicine, New York, NY, USA. ^[2] Drexel University, Philadelphia, PA, USA. ^[3] University of Minnesota, Minneapolis, MN, USA. ^[4] Long Beach Memorial Hospital, Long Beach, CA, USA. ^[5] Case Western Reserve University, Cleveland, OH, USA. ^[6] Maine Medical Center, Portland, ME, USA. ^[7] Oregon Health & Science University, Portland, OR, USA. ^[8] National Urea Cycle Disorders Foundation, Pasadena, CA, USA. ^[9] Baylor College of Medicine, Houston, TX, USA. ^[10]

关键词 Biomarker Glycerol phenylbutyrate Phenylacetate Phenylbutyrate Urea cycle disorder Urinary phenylacetylglutamine

DOI 10.1016/j.ymgmr.2015.09.003

PMID 28649536

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览30

Molecular genetics and metabolism reports

2015年5卷

12-14页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.

Molecular genetics and metabolism reports

相似文献

Molecular genetics and metabolism reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.

Molecular genetics and metabolism reports

相似文献

Molecular genetics and metabolism reports

相关期刊

检索历史清除